Does BELANTAMAB MAFODOTIN-BLMF Cause Plasma cell myeloma? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Plasma cell myeloma have been filed in association with BELANTAMAB MAFODOTIN-BLMF. This represents 10.0% of all adverse event reports for BELANTAMAB MAFODOTIN-BLMF.
15
Reports of Plasma cell myeloma with BELANTAMAB MAFODOTIN-BLMF
10.0%
of all BELANTAMAB MAFODOTIN-BLMF reports
8
Deaths
2
Hospitalizations
How Dangerous Is Plasma cell myeloma From BELANTAMAB MAFODOTIN-BLMF?
Of the 15 reports, 8 (53.3%) resulted in death, 2 (13.3%) required hospitalization.
Is Plasma cell myeloma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELANTAMAB MAFODOTIN-BLMF. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does BELANTAMAB MAFODOTIN-BLMF Cause?
Death (32)
Keratopathy (11)
Visual impairment (11)
Ocular toxicity (10)
Condition aggravated (9)
Plasma cell myeloma refractory (9)
Disease progression (7)
Dry eye (7)
Fatigue (7)
Visual acuity reduced (7)
What Other Drugs Cause Plasma cell myeloma?
LENALIDOMIDE (14,191)
DEXAMETHASONE (9,207)
POMALIDOMIDE (7,023)
BORTEZOMIB (6,683)
IXAZOMIB (3,249)
DARATUMUMAB (2,980)
CARFILZOMIB (2,238)
CYCLOPHOSPHAMIDE (2,058)
THALIDOMIDE (1,652)
SELINEXOR (1,046)
Which BELANTAMAB MAFODOTIN-BLMF Alternatives Have Lower Plasma cell myeloma Risk?
BELANTAMAB MAFODOTIN-BLMF vs BELATACEPT
BELANTAMAB MAFODOTIN-BLMF vs BELIMUMAB
BELANTAMAB MAFODOTIN-BLMF vs BELINOSTAT
BELANTAMAB MAFODOTIN-BLMF vs BELUMOSUDIL
BELANTAMAB MAFODOTIN-BLMF vs BELVIQ